[home]
[thesaurus]
Click Here to return To Results
Randomized, Double-Blind, Dose-Comparison Study of Glatiramer Acetate in Relapsing-Remitting MS
Neurol 68:939-944, Cohen,J.A.,et a, 2007
See this aricle in Pubmed
Article Abstract
Glatiramer acetate (GA) 40 mg was safe and well tolerated. The overall efficacy results suggested that a 40-mg dose of GA may be more effective than the currently approved 20-mg daily dose in reducing MRI activity and clinical relapses.
Related Tags
(click to filter results - removes previous filter)
cop 1
efficacy
MRI
MRI,abnormal
multiple sclerosis
multiple sclerosis,relapsing
multiple sclerosis,treatment of
safety
treatment of neurologic disorder
Click Here to return To Results